ESC 365 - Gut microbiota-derived imidazole propionate is a novel marker of cardiometabolic risk in patients with coronary artery disease

ESC2025 Premium Access

Gut microbiota-derived imidazole propionate is a novel marker of cardiometabolic risk in patients with coronary artery disease

Session: Pathophysiology in acute coronary syndromes (1)

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor F. Wenzl (Zurich, CH)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Florian A Wenzl

University of Zurich, Zurich (Switzerland)

4 presentations

1 follower

7 more presentations in this session

SMC-derived foam cells regulate atherosclerotic plaque stability via the crosstalk between ECM remodeling and WNT signaling

Speaker: Mx C. Li (Qingdao, CN)

Exploring the role of galectin-3 and pentraxin-3 as biomarkers in chronic coronary syndrome with atrial fibrillation: insights from an 87-patient cohort

Speaker: Doctor A. Oancea (Iasi, RO)

High apo-CIII level correlates with poor lipid status, pro-inflammatory and fibrotic biomarker profile, and adverse cardiovascular outcome in patients with recent acute coronary syndrome

Speaker: Ms S. Nilsson (Gothenburg, SE)

Cigarette smoking and release of the inflammatory chemokine CXCL10 (IP-10) after ST-elevation myocardial infarction

Speaker: Doctor L. Spray (Newcastle-Upon-Tyne, GB)

Hyperglycaemia-induced trained immunity alters monocyte function in type 2 diabetes patients after myocardial infarction

Speaker: Doctor T. Kufazvinei (Oxford, GB)

Access the full session

Pathophysiology in acute coronary syndromes (1)

Speakers: Doctor F. Wenzl, Mx C. Li, Doctor A. Oancea, Ms S. Nilsson, Doctor L. Spray...

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources